Find Academic Supervisors

Stephen W. HoagView profile

Professor

• Tablet Formulation
• Process Development
• Capsule Filling
• +28 more

Stephen W. Hoag is a Professor in the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy. His research spans pharmaceutical formulation, process development, and analytical technologies, with a strong emphasis on solid oral dosage forms and controlled release systems. University: University of Maryland School: School of Pharmacy Department: Department of Pharmaceutical Sciences Email: shoag@umaryland.edu Phone: (410) 706-6865 Fax: (410) 706-0346 Address: 20 North Pine Street, Baltimore, MD 21201 Education: B.S. in Biochemistry, University of Wisconsin–Madison, 1982 Ph.D. in Pharmaceutics, University of Minnesota, Twin Cities, 1990 Dr. Hoag's research is centered on two primary areas: (1) the development of systematic methods for formulating immediate and controlled release tablets, utilizing instrumented tablet presses, shear cell analysis, and process analytical technology (PAT) such as Near-Infrared (NIR) and Raman spectroscopy; and (2) the application of mathematical models to understand mass transport in hydrogels, including calcium alginate and silk-elastinlike protein polymers. His work on folic acid supplementation and prenatal vitamins has important public health implications due to the role of folic acid in preventing neural tube defects. Although no recent publications are listed in the provided text, his research output is evident through his co-editorship of the widely used reference work Pharmaceutical Dosage Forms: Tablets (3rd edition, 2008), and his leadership in developing best practices for PAT in pharmaceutical manufacturing. Scientific Awards: No specific awards mentioned in the provided text. Dr. Hoag has actively mentored a large number of graduate students, postdoctoral fellows, and visiting scientists, contributing significantly to pharmaceutical education and workforce development. His laboratory is equipped with state-of-the-art instrumentation for preformulation, formulation, tableting, coating, dissolution testing, and analytical characterization. The lab supports both non-clinical and GMP-level manufacturing research, enabling translational development of dosage forms. He also leads a hands-on short course on tablets and capsules, further extending his educational impact. Research Facilities: Thermal analysis (DSC, MDSC) Solubility and viscosity measurement Moisture analysis (Karl Fisher, LOD) Mechanical testing (Instron) Flow characterization (shear cell, angle of repose) Particle size analysis (laser diffraction, SEM, sieve) Tablet presses (Stoke’s B2, Manesty Beta, fully instrumented) Coating systems (fluid bed, pan coaters) UV/Vis, HPLC, GC, MS instrumentation Environmental stability chambers Granulation, milling, blending equipment Dissolution testing with autosampler

• Ocular Drug Delivery
• Nanoparticle Formulation
• Pharmaceutics
• +3 more

Cory Varner serves as a Visiting Instructional Assistant Professor and Faculty Instructor in the Department of Pharmaceutics and Drug Delivery at the School of Pharmacy, University of Mississippi (Oxford campus), with office location in Faser 125 and contactable via 662-915-7341. Education Bachelor of Science in Pharmaceutical Science, University of Mississippi (2017) Doctor of Philosophy in Pharmaceutical Science, University of Mississippi (2021) Research Interests His work concentrates on preformulation and formulation development of nanoparticles for ocular drug delivery , addressing critical challenges in ophthalmic therapeutics including bioavailability enhancement and extended drug residence time through nanocarrier systems. This research bridges pharmaceutical sciences with advanced drug delivery technologies targeting eye-specific applications. Scientific Awards No scientific awards documented in provided materials Advising and Grants No student advisees or grant funding details referenced

Hanne Hjorth TønnesenView profile

Professor

• Pharmaceutics
• Galenic Pharmacy
• Photoreactivity of Drugs
• +7 more

Hanne Hjorth Tønnesen is a Professor at the University of Oslo in the Department of Pharmacy , specializing in Pharmaceutics and Galenic Pharmacy . Her work focuses on photoreactivity of drugs, formulation technologies for poorly water-soluble drugs, and applications of natural deep eutectic solvents (NADES) in antimicrobial photodynamic therapy (aPDT). Academic Interests: Photostability, drug formulation, NADES, collagen-based systems, nanovehicles, and photodynamic therapy. Collaborations: Partners with institutions like the Nordic Institute of Dental Materials (Oslo), University of Iceland, University of Insubria (Italy), and Julius-Maximilians University of Würzburg (Germany). Her research explores photoreactivity and stability of pharmaceutical products , emphasizing innovative formulation strategies. Recent studies include NADES as anti-biofilm agents , bacteriocin delivery systems , and collagen hydrogels for targeted therapies. Publications highlight trends in antimicrobial photodynamic therapy , nanovehicle drug delivery , and photostability testing . She contributes to standardizing photostability guidelines for photosensitive drugs. Teaching: Leads courses in Personalized Drug Therapy , Biopharmacy , and New Drug Forms , mentoring future pharmacy professionals.

• Pharmaceutical Process Analytical Technology
• Freeze-Drying Process Development
• Process Analytical Technologies (PAT)
• +9 more

Professor Geoff Smith is a leading academic in Pharmaceutical Process Analytical Technology at De Montfort University, affiliated with the Leicester School of Pharmacy and the Pharmaceutical Technologies research group. He holds a PhD from the University of Brighton and a BPharm from the University of Bath, and has been instrumental in advancing freeze-drying and process analytical technologies. His research expertise lies in developing and applying novel sensing technologies for pharmaceutical manufacturing. Key areas include freeze-drying process development, impedance and dielectric spectroscopy, terahertz imaging, dynamic laser speckle, and electrostatic measurements for powder flow analysis. His work is strongly industry-oriented, focusing on enhancing process understanding and control through real-time, non-invasive monitoring. The recent publications highlight a strong trend in the application of Through-Vial Impedance Spectroscopy (TVIS) for lyophilization process optimization. Research spans from fundamental studies on ice nucleation and glass transition to practical applications in micro-collapse detection, heat transfer coefficient calculation, and container compatibility. There is also significant work on terahertz-based characterization of crystallinity and microneedle penetration, indicating a broader interest in advanced spectroscopic and imaging techniques for pharmaceutical quality assurance. Scientific Awards and Recognition: While specific awards are not listed in the provided text, his extensive publication record, multiple patents, and leadership in Innovate UK-funded projects reflect high recognition in his field. Professor Smith has successfully secured substantial research funding from Innovate UK and the Technology Strategy Board, including grants such as EXTALcoat, FastLyo, AtlasBio, BioStaRT, and LyoDEA, involving collaborations with industry leaders like GEA, AstraZeneca, and Sanofi. He has supervised numerous PhD projects and plays a key role in teaching Pharmaceutical Quality by Design and Good Manufacturing Practice. He leads the Pharmaceutical Technologies group, which he restructured to include chemists, physicists, and engineers, fostering a multidisciplinary approach to solving current pharmaceutical challenges. Laboratories and Research Groups: He leads the Pharmaceutical Technologies research group at DMU, which focuses on developing and applying advanced analytical techniques like TVIS, terahertz spectroscopy, and laser speckle imaging for pharmaceutical process understanding and control. The group operates at the intersection of pharmaceutical science, engineering, and material science, with a strong emphasis on industrial collaboration and technology transfer.

Levon BostanianView profile

Professor

• Preformulation
• Drug Delivery Systems
• Bioavailability Enhancement
• +1 more

Dr. Levon Bostanian is a Professor of Pharmaceutics in the Division of Basic Pharmaceutical Sciences at Xavier University of Louisiana's College of Pharmacy. He teaches Pharmaceutical Calculations, Pharmaceutics Lecture and Lab, and Biopharmaceutics. His research focuses on designing novel drug delivery systems to enhance drug bioavailability, encompassing preformulation, formulation, and stability studies. Education: Ph.D. in Pharmaceutics and Pharmaceutical Chemistry from The Ohio State University (1995), M.S. in Pharmaceutics from University of Alexandria (1989), B.S. in Pharmacy from University of Alexandria (1984). Research interests center on overcoming bioavailability challenges through innovative drug delivery platforms, with applications in compounding, nanotechnology, and analytical method development. Recent publications demonstrate consistent focus on nanoparticle therapeutics and stability testing, with applications ranging from antiparasitic agents to antidiabetic treatments. Awards include a U.S. patent for small particle formation technology. Dr. Bostanian's laboratory focuses on translational pharmaceutics, bridging formulation science with clinical applications.

Richard HaynesView profile

Professor

• Medicinal Chemistry
• Drug Design
• Infectious Diseases
• +7 more

Professor Richard K. Haynes is a Senior Principal Research Fellow at the Rural Health Research Institute , Charles Sturt University. His work bridges medicinal chemistry , pharmacology , and global health , focusing on drug development for malaria , tuberculosis , and cancer . He also holds adjunct positions at the Hong Kong University of Science and Technology and North-West University . Education : PhD in Organic Chemistry (University of Western Australia), Postdoctoral work (University of Karlsruhe, Imperial College London) Research Interests : Mechanism of action of artemisinin derivatives, rational drug combinations, non-neurotoxic antimalarials, and therapies for parasitic/bacterial diseases. His recent publications highlight advancements in self-emulsifying drug delivery systems , redox-active antimalarials , and drug repurposing for viral infections. Notably, artemisone—a non-neurotoxic artemisinin derivative—has shown clinical promise in malaria and cytomegalovirus treatments. Scientific Awards & Memberships : Fellow of the Royal Society of Chemistry (FRSC) Fellow of the Royal Australian Chemical Institute (FRACI) A-rated researcher, South African National Research Foundation (2014–2020) Member, American Association for the Advancement of Science (AAAS) Haynes collaborates with the World Health Organization (TDR/WHO) and pharmaceutical companies, contributing to UN Sustainable Development Goals through innovations in tropical disease research and sustainable drug production.

Laura WatersView profile

Professor

• Pharmaceutical Analysis
• Thermodynamics of Drug Interactions
• Pharmaceutical Formulation Development
• +3 more

Laura Waters is a Professor of Pharmaceutical Analysis within the Department of Pharmacy at the School of Applied Sciences , University of Huddersfield. She holds roles as Treasurer of the Royal Society of Chemistry’s local section, a member of the JPAG committee, and is affiliated with the Pharmaceutics and Drug Delivery Centre and the Institute of Skin Integrity and Infection Prevention . She is also a Fellow of the Higher Education Academy, a National Public Engagement Ambassador, and a STEM ambassador. Research Interests: Her work focuses on the interface of chemistry and pharmaceutics, particularly in developing analytical techniques (e.g., calorimetry and chromatography) to study drug interactions, formulation optimization, and skin permeability. Key areas include surfactant dynamics, nanocomposite drug delivery systems, and thermodynamic studies of drug-excipient interactions. Publications: Recent work emphasizes polysorbate interactions, CMC determination, and predictive models for skin permeability using HuskinDB. Her research spans drug delivery systems, formulation stability, and transdermal delivery innovations. Accolades & Engagement: Recognized as a Fellow of the HEA and engaged in public outreach, including BBC media appearances on topics like haircare and drug formulation. She actively mentors PhD candidates and has supervised over 10 research projects. Labs & Teams: Leads a research group at the Pharmaceutics and Drug Delivery Centre, collaborating on projects funded by external grants. Her work aligns with UN Sustainable Development Goals related to health and innovation.

José I. BorrellView profile

Professor

• Pharmaceutical Chemistry
• Organic Synthesis
• Biochemistry
• +4 more

Professor José I. Borrell is affiliated with the IQS School of Engineering at Universitat Ramon Llull , where he leads the Pharmaceutical Chemistry Group . His research focuses on drug design for hematological cancers , particularly targeting CXCR4 and kinase pathways like IRAK4 , FGFR2 , and IGF1R . He directs key projects such as DisX4lymph (CXCR4 allosteric inhibitors) and PROTEOblood (proteinopathy analysis in blood cancers). His projects span 2003-2025 with funding from the State Research Agency , European Commission , and AGAUR . Recent work includes covalent reversible IRAK4 inhibitors , non-symmetrical CXCR4 antagonists , and structure simplification methods for dual kinase inhibitors. His team employs molecular modeling and virtual screening to develop novel therapeutics. Scientific production shows 161 publications with 2615 Scopus citations. Active collaborations within PROTEOblood and with researchers like R. Estrada-Tejedor and J. Teixidó highlight his role in B-cell lymphoma and pancreatic cancer research. The Pharmaceutical Chemistry Group maintains focus on oxidative dehydrogenation and heterocyclic synthesis since 2017.

Susan Weng LarsenView profile

Associate Professor

• Drug delivery systems
• Pharmaceutical Physical Chemistry
• Intra-articular drug delivery
• +7 more

Susan Weng Larsen serves as an Associate Professor in the Department of Pharmacy within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her academic career at the institution spans over two decades, beginning as an Assistant Professor in the Department of Pharmaceutics and Analytical Chemistry in 2003, and advancing to her current position in 2008. Education: PhD in Pharmaceutics from The Danish University of Pharmaceutical Sciences (2003) MSc Pharm degree Dr. Larsen's research focuses on advanced drug delivery systems with particular expertise in intra-articular oil injectables for prolonged analgesia, novel prodrug principles for localized NSAID action, and in situ suspension-forming injectables for sustained drug delivery. Her work encompasses the development of in vitro release methods to characterize depot formulations for subcutaneous and intra-articular administration, as well as investigations into liquid crystalline nanostructures as sustained release platforms. Additional research interests include osteoarthritis therapy through articular cartilage targeting and lymphatic biodistribution of nanocarriers based on cubosomes and hexosomes. Her recent publications (2022-2024) demonstrate continued innovation in pharmaceutical analysis and drug delivery, with particular emphasis on advanced imaging techniques like UV-Vis for characterizing injectable formulations, development of bio-relevant testing methods, and investigations into novel drug carriers including graphene oxide composites. Her work spans multiple therapeutic areas including diabetes (insulin delivery), ophthalmology (glaucoma treatments), oncology (intra-tumoral delivery), and antifungal therapy. As an educator, Dr. Larsen teaches Pharmaceutical Physical Chemistry and Pharmaceutical Preformulation courses, and supervises bachelor, master, and PhD students in the Pharmacy program. Her research has resulted in 74 documented research outputs including journal articles, patents, book chapters, and conference presentations, reflecting substantial contributions to pharmaceutical sciences. Dr. Larsen maintains active research collaborations across multiple departments at the University of Copenhagen, including her guest researcher position in the Department of Drug Design and Pharmacology, and has established herself as a significant contributor to the development of advanced drug delivery methodologies and analytical techniques in pharmaceutical research.

Asish DuttaView profile

Professor

• Pharmaceutical Analysis
• Drug Stability Studies
• Natural Products Research
• +4 more

Dr. Asish K. Dutta serves as Chair and Professor of Pharmaceutical Sciences at Notre Dame of Maryland University's School of Pharmacy, directing the Masters in Pharmaceutical Sciences program. He holds a PhD from the University of Mississippi (2006) and a B Pharm from Jadavpur University (1996). With 23+ years of academic experience, he specializes in analytical method development, drug stability, and natural product characterization. Education: Ph.D., Pharmaceutics, University of Mississippi (2000-2006) B. Pharm, Jadavpur University (1992-1996) Research focuses on HPLC stability-indicating methods, drug-excipient interactions, and formulation development for curcumin, black cohosh, and antimalarials. His work spans solid/semisolid dosage forms, bioadhesive films, and molecular modeling. Active in professional leadership roles including AACP Pharmaceutics Section Chair and AAPS MSE Ambassador Program Chair. Awarded over 15 grants and travel awards including multiple Pangborn Travel Awards and University of Mississippi fellowships. Published 20+ peer-reviewed articles and book chapters, with presentations at AACP and AAPS national meetings. Labs: Directs pharmaceutical analysis and formulation laboratories at NDMU. Advises on interdisciplinary projects integrating preformulation, stability, and drug delivery systems.

Annalisa BiancheraView profile

Associate Professor

• Drug Delivery
• Biomaterials
• Pharmaceutical Technology
• +5 more

Annalisa Bianchera is an Associate Professor at the University of Parma, Department of Food and Pharmaceutical Sciences. Her academic work focuses on pharmaceutical technology, drug delivery systems, and biomaterials. Teaches courses in biomaterials, pharmaceutical technologies, and digital marketing in pharmacy Research spans drug delivery , 3D printing in medicine , and biomaterials for advanced therapies Key contributions in nasal administration , pulmonary delivery , and controlled release systems Her recent publications highlight innovations in polyelectrolytic nanocomplexes , ocular drug delivery , and green formulation techniques . While no formal scientific awards are listed in publicly available data, her work emphasizes practical advancements in pharmaceutical sciences. Contact: annalisa.bianchera@unipr.it

• Pharmaceutical Engineering
• Drug Delivery Systems
• Crystal Engineering
• +6 more

Professor Anant Paradkar is a Professor of Pharmaceutical Engineering at the University of Bradford's School of Pharmacy & Medical Sciences, and Director of the Centre for Pharmaceutical Engineering Science. He holds an Interdisciplinary Chair in Pharmaceutical Engineering Science and has over 20 years of academic experience, including roles in India and the UK. His research focuses on pharmaceutical process development, crystal engineering, nanoparticulate systems, and solid-state pharmaceutics, with a strong emphasis on green technologies like hot melt extrusion and sono-crystallisation. Education: PhD in Pharmaceutics. Current research includes solvent-free continuous co-crystallization, amorphous systems, and liquid crystalline formulations for drug delivery. He collaborates internationally, notably with Sichuan University (China) and India's National Chemical Laboratory. Awards include the Yorkshire Enterprise Fellowship, UKIERI Fellowship, and Young Pharmacy Teacher Award. Research Interests: Process optimization, formulation development for poorly soluble drugs, QbD, PAT, and nanoparticulate drug delivery systems for neurodegenerative diseases and cancers. His work bridges engineering and pharmacy, addressing challenges in scalability and commercialization. Grants & Funding: EPSRC funding for co-crystallization projects, Yorkshire Enterprise Fellowship, and multiple Indian grants (UGC, DST, MoD). Current projects include propolis product development and curcumin systems for Alzheimer's treatment. Advising: Supervised 10 PhD and 45 MPharm students, currently co-supervising 15 PhD candidates. Publications exceed 90 papers, with a focus on pharmaceutical engineering and formulation science. Labs & Teams: Leads the Centre for Pharmaceutical Engineering Science, fostering interdisciplinary collaboration in pharmaceutical process innovation.

• Pharmaceutical Sciences
• Drug Delivery Systems
• Pharmaceutical Formulation
• +3 more

Ayman Allahham is a Lecturer in Pharmaceutics at RMIT University's School of Health and Biomedical Sciences. With over 10 years of experience, he specializes in pharmaceutical science education, emphasizing quality assurance and accreditation standards. His academic journey includes completing Honours and a PhD at Monash University. He has fostered industry collaboration through training programs, student projects, and industrial partnerships. Research interests focus on pharmaceutical physicochemical properties, formulation development, and drug delivery systems (respiratory and gastrointestinal). His work explores dissolution kinetics, drug stability, and the application of natural antioxidants in disease management. Teaching interests include drug interactions, particle agglomeration, complementary medicines, and bioavailability challenges. Recent research highlights medication safety, complementary medicine consumer behavior, and innovative drug delivery technologies. He actively seeks collaborations to advance pharmaceutical education and industry linkages. Open to supervising postgraduate students in areas such as medication safety, formulation stability, and nanotechnology in drug delivery. Industry experience includes quality control (QC) roles and regulatory compliance in the pharmaceutical sector, alongside administrative and teaching roles in Saudi Arabian tertiary institutions.

Kacsó Irina ElisabetaView profile

Researcher

• Pharmaceutical Chemistry
• Supramolecular Chemistry
• Drug-Cyclodextrin Inclusion Complexation
• +6 more

Dr. Kacsó Irina Elisabeta is a recognized researcher (R2 - CS III) at the National Institute for Research and Development of Isotopic and Molecular Technologies (INCDTIM) in Cluj-Napoca, Romania. She works within the Isotopic and Molecular Technologies Department as part of the Complex Molecular and Biomolecular Systems Research Group. Her educational background includes an MSc in Chemistry (1991) and a PhD in Organic Chemistry (1999), both from Babeș-Bolyai University in Cluj-Napoca, Romania. Dr. Kacsó specializes in pharmaceutical chemistry with particular expertise in drug-cyclodextrin inclusion complexation, polymorph analysis, thermal analysis (DSC), and FTIR spectroscopy. Her research focuses on obtaining, characterizing, and preformulating solid forms and supramolecular compounds of biologically active substances. She applies instrumental analysis techniques to both organic and inorganic compounds. She has been actively involved in numerous research projects spanning pharmaceutical development, cultural heritage analysis, water management solutions, and biomaterials. Her work demonstrates strong interdisciplinary collaboration across chemistry, medicine, engineering, and cultural preservation fields. Dr. Kacsó has served as a team leader or key researcher in multiple significant projects including COFUND-WATER4ALL-DIME (2024-2027), SYNERGISTIC ACTIVES SYSTEMS FOR REGENERATIVE COSMETICS (2022-2024), and several others focused on pharmaceutical compounds, cultural heritage authentication, and advanced biomaterials. She maintains an active research profile with Web of Science ResearcherID: D-9552-2014 and has contributed to numerous publications and patents through her project work.

• Pharmaceutical Technology
• Drug Delivery Systems
• Micellar Solutions
• +6 more

Rosanna Stancanelli is an Associate Professor in Pharmaceutical Technology and Application (CHIM/09) at the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina. She holds a Pharmacy degree with full honors from the University of Messina (1997) and a PhD in Pharmaceutical Sciences (2001). Her academic career includes positions as University Researcher (2006) and Associate Professor (2014). She has been actively involved in teaching pharmaceutical technology, biotechnology, and legislation courses for Pharmacy and Pharmaceutical Chemistry programs. Degree in Pharmacy, University of Messina (1997) PhD in Pharmaceutical Sciences, University of Messina (2001) University Researcher, Department of Pharmaceutical Sciences (2006) Associate Professor, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences (2014) Professor Stancanelli's research focuses on pharmaceutical technology, drug delivery systems, and analytical chemistry. Her work centers on developing and characterizing novel drug delivery systems including solid lipid nanoparticles, cyclodextrin inclusion complexes, and polymeric nanoparticles. She investigates the physicochemical properties of these systems and their applications for improved drug delivery, particularly for bioactive compounds like flavonoids, anticancer agents, and other pharmaceutical substances. Her research combines advanced analytical techniques including neutron scattering, spectroscopy, and microscopy to understand the structural and dynamic properties of drug delivery systems. Her recent publications (2019-2025) demonstrate a strong focus on nanotechnology-based drug delivery, particularly solid lipid nanoparticles for flavonoid delivery (rutin, morin, naringenin), cyclodextrin inclusion complexes, and chitosan-based systems. These works span pharmaceutical technology, analytical chemistry, and biomedical applications, with particular emphasis on cancer therapy, antibacterial activity, and nasal drug delivery systems. FFABR Unime 2019 university research funding FFABR Unime 2021 research funding Guest Editor for Special Issue 'Nanosystems in pharmaceutical technology' in Molecules journal Professor Stancanelli has supervised numerous student theses and has been actively involved in teaching and curriculum development. She has served on various committees including PhD program committees, admission exam committees, and quality assurance groups. Her teaching portfolio includes Pharmaceutical Industry Plants, Biotechnology of Drug Technology, Pharmaceutical Technology, and Pharmaceutical Legislation courses for various Pharmacy and Pharmaceutical Chemistry programs. She has also participated in international research collaborations and has conducted experiments at facilities including the Institut Max Von Laue Paul Langevin and the ISIS Facility at the Rutherford Appleton Laboratory.